NDC 0591-0822 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0822
- Package NDCs from labels
- 0591-0822-01, 0591-0822-05
- Manufacturer
- Watson Labs
- Effective date
- 2007-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Watson Labs | Watson Labs | 2007-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0822-01 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0822-05 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Naproxen | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Naproxen | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Croscarmellose sodium | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Povidone | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic black iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic red iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic yellow iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 9c963e77-6e05-47d0-a8d3-e581777377b9 | 2021-08-19 | Boxed warning, Warnings, Adverse reactions | 198013 198012 |
| NAPROXEN | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 32693390-763b-46dd-b821-65a7bf3c6671 | 2021-04-26 | Warnings | 198014 |
| Naproxen | NAPROXEN | Proficient Rx LP | fc3ee94a-adb7-411e-a662-2f2c6ddbabaf | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Proficient Rx LP | 3e4e5371-d796-47c7-95c1-d99e82a0b282 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 3e14f839-d1e4-44df-a457-29f005b3e62e | 2020-12-15 | Boxed warning, Warnings, Adverse reactions | 198014 |
| NAPROXEN | NAPROXEN | Bryant Ranch Prepack | 5d399bf3-db49-411a-91b9-b410d702a65a | 2020-12-14 | Warnings | 198013 198012 |
| Naproxen | NAPROXEN | Exelan Pharmaceuticals, Inc. | 46dbdb95-a0d0-4410-8d64-b22763b12af7 | 2020-08-17 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| NAPROXEN | NAPROXEN | TIME CAP LABORATORIES | 4350a2d9-5228-460e-b7b1-27e8fa846787 | 2018-10-09 | Warnings | 198014 198013 198012 |
| Naproxen | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | e2347581-90da-429a-b17c-cffd0039fb86 | 2017-10-23 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | NCS HealthCare of KY, Inc dba Vangard Labs | 62a12771-bde9-4bc3-9ce9-672c8e31f020 | 2017-10-12 | Boxed warning, Warnings, Adverse reactions | 198014 |
| 3BB032FE-E776-C7C1-DB24-103F409F7ED4 | AF3CA49D-65E0-47BC-A2E6-A38277DB9408 | 2007-02-06 | Boxed warning, Warnings, Adverse reactions | 3BB032FE-E776-C7C1-DB24-103F409F7ED4 AF3CA49D-65E0-47BC-A2E6-A38277DB9408 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.